FALZONI, Simonetta
 Distribuzione geografica
Continente #
NA - Nord America 11.860
EU - Europa 9.502
AS - Asia 5.597
SA - Sud America 843
Continente sconosciuto - Info sul continente non disponibili 236
AF - Africa 122
OC - Oceania 16
Totale 28.176
Nazione #
US - Stati Uniti d'America 11.532
FI - Finlandia 5.971
SG - Singapore 2.127
CN - Cina 1.374
DE - Germania 1.051
IT - Italia 804
VN - Vietnam 647
BR - Brasile 640
HK - Hong Kong 419
UA - Ucraina 396
GB - Regno Unito 294
TR - Turchia 269
RU - Federazione Russa 236
BD - Bangladesh 188
FR - Francia 188
PL - Polonia 188
CA - Canada 147
JP - Giappone 138
SE - Svezia 113
IN - India 104
ID - Indonesia 85
MX - Messico 85
AR - Argentina 70
NL - Olanda 55
IQ - Iraq 39
ZA - Sudafrica 38
LT - Lituania 37
EC - Ecuador 33
ES - Italia 28
PK - Pakistan 27
CO - Colombia 26
PH - Filippine 25
BE - Belgio 22
VE - Venezuela 22
CR - Costa Rica 21
UZ - Uzbekistan 21
AT - Austria 17
IE - Irlanda 17
PY - Paraguay 17
SA - Arabia Saudita 17
AU - Australia 15
JM - Giamaica 15
CZ - Repubblica Ceca 13
AE - Emirati Arabi Uniti 12
IL - Israele 12
KE - Kenya 12
MA - Marocco 12
PE - Perù 12
CL - Cile 11
EG - Egitto 11
MY - Malesia 11
TN - Tunisia 11
IR - Iran 10
DZ - Algeria 9
LV - Lettonia 9
NI - Nicaragua 9
KR - Corea 8
OM - Oman 8
TT - Trinidad e Tobago 8
AZ - Azerbaigian 7
BO - Bolivia 7
DK - Danimarca 7
EE - Estonia 7
NP - Nepal 7
PA - Panama 7
RO - Romania 7
TH - Thailandia 7
BB - Barbados 6
CH - Svizzera 6
GT - Guatemala 6
HN - Honduras 6
SK - Slovacchia (Repubblica Slovacca) 6
CW - ???statistics.table.value.countryCode.CW??? 5
ET - Etiopia 5
JO - Giordania 5
MD - Moldavia 5
PS - Palestinian Territory 5
BG - Bulgaria 4
GR - Grecia 4
KZ - Kazakistan 4
LB - Libano 4
RS - Serbia 4
UY - Uruguay 4
AL - Albania 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
MU - Mauritius 3
PR - Porto Rico 3
PT - Portogallo 3
SN - Senegal 3
SV - El Salvador 3
TW - Taiwan 3
BJ - Benin 2
BS - Bahamas 2
CI - Costa d'Avorio 2
GE - Georgia 2
GP - Guadalupe 2
Totale 27.917
Città #
Helsinki 5.809
Ashburn 1.422
Singapore 1.321
San Jose 880
Fairfield 801
Woodbridge 781
Santa Clara 533
Houston 495
Chandler 483
Council Bluffs 463
Beijing 452
Jacksonville 438
Hong Kong 411
Munich 387
Ann Arbor 354
Seattle 302
Wilmington 273
Ferrara 262
Cambridge 251
Dallas 215
Ho Chi Minh City 202
Los Angeles 186
New York 184
Warsaw 171
Hanoi 157
Izmir 142
Nanjing 133
Tokyo 127
Princeton 113
Addison 106
Lauterbourg 99
San Diego 86
Boardman 80
Shanghai 78
Milan 70
The Dalles 65
Buffalo 60
São Paulo 58
Chicago 57
Atlanta 55
Jakarta 54
Turku 54
Mexico City 49
Orem 49
Toronto 46
London 45
Phoenix 44
Nanchang 39
Rome 38
Brooklyn 37
Dong Ket 37
Montreal 37
Shenyang 37
Da Nang 36
Denver 36
Frankfurt am Main 35
Moscow 35
Dearborn 33
Bremen 32
Chennai 32
San Francisco 32
Hebei 30
Hefei 30
Tianjin 26
Changsha 25
Nuremberg 25
Boston 24
Columbus 23
Jiaxing 23
Johannesburg 23
North Bergen 23
Amsterdam 22
Hải Dương 22
Manchester 22
Stockholm 22
Washington 21
Brussels 20
Jinan 20
Tashkent 20
Brasília 19
Haiphong 18
Naples 17
Norwalk 17
Philadelphia 17
San José 17
Baghdad 16
Bologna 16
Poplar 16
Rio de Janeiro 15
Augusta 14
Dublin 14
Falkenstein 14
Jyväskylä 14
Ningbo 14
San Mateo 14
Charlotte 13
Curitiba 13
Guangzhou 13
Istanbul 13
Redwood City 13
Totale 20.137
Nome #
A new luciferase target to the extracellular surface of the plasma membrane reveals a new pathway for ATP release in live intact cells. 2.251
A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion 2.178
A new method for measuring local ATP release at the extracellular surface of live intact cells 2.101
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 441
Characterization of P2X7 isoform B sheds light on the role of pore versus channel activity in P2X7 mediated life and death. 393
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7 356
P2X7 targeting inhibits growth of human mesothelioma 323
1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: Correlation with histological variants and clinical parameters 310
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 300
The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein 297
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment 290
Amyloid beta-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine 287
Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells 283
ATP-mediated cytotoxicity in microglial cells 278
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 275
P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration 258
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 254
The P2X7 Receptor in Infection and Inflammation 253
Plasma P2X7 receptor correlation with plasma C-reactive protein in infectious diseases 249
ATP receptors and giant cell formation 244
ATP secreted by endothelial cells blocks CX 3CL1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y 11 receptor activation 243
The antibiotic polymyxin B modulates P2X7 receptor function 243
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination 242
Blockade of P2X7 receptor inhibits formation of multinucleated giant cells. 236
The P2X7 receptor is a key modulator of aerobic glycolysis. 235
Dysfunctional inflammasome in Schnitzler's syndrome 235
Non-nucleotide agonists triggering P2X7 receptor activation and pore formation 234
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance 233
Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells 230
Purinoceptor function in the immune system 229
Altered IL-1ß secretion in a patient affected by Schnitzler's syndrome 222
In-vivo measurement of the extracellular ATP concentration by bio-luminescence: The pmeLUC probe 221
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 221
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 218
Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical Performance 218
P2 receptors in cancer progression and metastatic spreading 217
ATP in the tumour microenvironment drives expression of nfP2X(7), a key mediator of cancer cell survival 217
Cellular biosensors for the identification of fetal hemoglobin inducers 211
Hemophagocytic Lymphohistiocytosis in a Patient with Relapsed Chronic Lymphocytic Leukemia Treated with Ibrutinib 211
The P2X7 receptor-interleukin-1 liaison 210
CYTOLYTIC P2X PURINOCEPTORS 210
Trophic activity of a naturally occuring isoform of the P2X7 receptor 206
Altered IL-1 beta secretion in a patient affected by Schintzler's syndrome 206
The P2 purinergic receptors of human dendritic cells: Identification and coupling to cytokine release 204
Expression of the P2X7 receptor and metabolic adaptation in serum and glucose deprivation 203
Extarcellular ATP triggers IL-1beta release by activating the purinergic P2Z receptor of human macrophages 201
Extracellular ATP is increased by release of ATP-loaded microparticles triggered by nutrient deprivation 199
Stable expression in HEK293 cells and characterization of P2X7 isoform B: new hints on P2X7 mediated cell survival. 196
High glucose modulates P2X7 receptor-mediated function in human primary fibroblasts 196
Association of Hypomorphic P2X7 Receptor Genotype With Age 195
Activation of microglia by amyloid  requires P2X7 receptor expression 194
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4 194
The P2X7 Receptor 489C>T Gain of Function Polymorphism Favors HHV-6A Infection and Associates With Female Idiopathic Infertility 193
The P2X7-inflammasome connection: a novel pathway in autoinflammatory diseases. 190
P2 purinoceptors in the immune system 189
Association of 1513CC P2X7 receptor genotype with age 187
P2X7 receptor has a key role in multinucleated giant cells formation. 184
CHIMERIC PROTEINS FOR MEASURING ATP CONCENTRATIONS IN PERICELLULAR SPACE AND RELATED SCREENING METHOD 182
Use of luciferase probes to measure ATP in living cells and animals 182
Role of the purinergic P2Z receptor in spontaneous cell death in j774 macrophage cultures 181
The Purinergic P2Z Receptor of Human Macrophage Cells: Characterization and Possible Physiological Role 181
Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7 180
Pharmacological blockade of the P2X7 receptor reverses retinal damage in a rat model of type 1 diabetes 178
The P2Z/P2X7 receptor of microglial cells: A novel immunomodulatory receptor 178
Expression and function of the P2X7 receptor in human osteoblasts: The role of NFATc1 transcription factor 176
Detecting adenosine triphosphate in the pericellular space 175
Increased proliferation rate of lymphoid cells transfected with the P2X7 ATP receptor 173
P2X7 receptor and polykarion formation 172
The P2X7 receptor for extracellular nucleotides: a novel player in bone remodelling 172
The P2X7 receptor and pannexin-1 are both required for the promotion of multinucleated macrophages by the inflammatory cytokine GM-CSF 172
Role of the P2X7 receptor in in vitro and in vivo glioma tumor growth 172
Signalling by extracellular nucleotides in health and disease 172
The Concise Guide to PHARMACOLOGY 2023/24: Ion channels 170
The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism 168
P2X7: a novel growth-stimulating receptor in B lymphoblastoid cells 167
The P2X7 Receptor is a Master Regulator of Microparticle and Mitochondria Exchange in Mouse Microglia 165
P2X7 Receptor Activity Limits Accumulation of T Cells within Tumors 164
Nucleotide receptor: an emerging family of regulatory molecules in blood cells 159
Modulation of Cell Energy Metabolism by the P2X7 Receptor 158
Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra 158
Purinergic signaling in giant cell formation 158
Expression of the P2X7 receptor add metabolic adaptation in serum and glucose deprivation 154
Mouse dendritic cells express the P2X7 purinergic receptor: Characterization and possible participation in antigen presentation 154
Immunological evidence of an early seroconversion to oncogenic Merkel cell polyomavirus in healthy children and young adults 152
Effects of extracellular ATPand adenosine on osteoclast development 152
Blocking P2X7 by intracerebroventricular injection of P2X7-specific nanobodies reduces stroke lesions 149
Mitochondrial Localization and Function of Adenosine Receptors 147
Extracellular ATP causes ROCK I-dependent bleb formation in P2X(7)-transfected HEK293 cells 146
Assessing Extracellular ATP as Danger Signal In Vivo: The pmeLuc System 144
The Coming of Age of the P2X7 Receptor in Diagnostic Medicine 143
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells 141
Fetal bovine serum contains biologically available ATP 140
Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin 140
Extracellular ATP in cancer 138
Islet-Derived eATP Fuels Autoreactive CD8+ Cells and Facilitates the Onset of Type 1 Diabetes 137
Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. 134
Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X(7) receptor 133
P2Z purinergic receptor expression correlates with spontaneous cell death of J774 macrophages in vitro 131
SCHNITZLER AND SAPHO SYNDROMES: A MOLECULAR LINK BETWEEN P2X7 RECEPTOR AND INFLAMMASOME COMPLEX 130
The purinergic P2Z receptor is expressed by human macrophages and upregulated by gamma interferon 129
Totale 26.301
Categoria #
all - tutte 105.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.573
Totale 110.046


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022932 0 0 0 37 40 35 80 51 29 84 111 465
2022/20231.090 119 66 35 133 183 141 39 127 146 10 65 26
2023/2024711 76 86 33 15 86 108 37 60 16 8 29 157
2024/20253.273 67 78 205 143 335 409 207 214 584 297 385 349
2025/202613.556 876 290 604 925 1.202 469 1.051 448 6.317 821 325 228
2026/20272.230 222 420 799 789 0 0 0 0 0 0 0 0
Totale 28.176